Overview

Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients

Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
0
Participant gender:
All
Summary
This is a randomized, controlled multicenter clinical trial. The purpose of this study is to compare the continuous infusion of vancomycin with intermittent infusion regarding the effectiveness to reach the target serum level and the relationship between infusion type and nephrotoxicity in critically ill patients.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Vancomycin
Criteria
Inclusion Criteria:

- Critically ill patients

- Treatment with vancomycin

- Preserved renal function.

Exclusion Criteria:

- Cystic fibrosis

- Chronic renal failure

- Acute renal failure

- Having received vancomycin in the last 24 hours

- Vancomycin hypersensibility